These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 19618299)
1. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease. Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299 [TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study. Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819 [TBL] [Abstract][Full Text] [Related]
4. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals. DeBoer MD; Filipp SL; Gurka MJ Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283 [TBL] [Abstract][Full Text] [Related]
5. Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease. Gui MH; Ling Y; Liu L; Jiang JJ; Li XY; Gao X Chin Med J (Engl); 2017 Mar; 130(6):669-677. PubMed ID: 28303849 [TBL] [Abstract][Full Text] [Related]
6. TG/HDL-C ratio is positively associated with risk and severity of CHD among NAFLD patients: a case control study. Cheng B; Yi Y; Chen M; Wei Y; Su X; Chen P; Lin X; Gu Y; Li T; Xu C; Liu Q; Li B Front Endocrinol (Lausanne); 2024; 15():1383489. PubMed ID: 39027474 [TBL] [Abstract][Full Text] [Related]
7. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Zabetian A; Hadaegh F; Azizi F Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915 [TBL] [Abstract][Full Text] [Related]
8. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China. Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915 [TBL] [Abstract][Full Text] [Related]
9. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients. Mayer O; Bruthans J; Seidlerová J; Karnosová P; Vaněk J; Hronová M; Gelžinský J; Cvíčela M; Wohlfahrt P; Cífková R; Filipovský J Eur J Intern Med; 2018 Jan; 47():55-61. PubMed ID: 28755847 [TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study. Rachas A; Raffaitin C; Barberger-Gateau P; Helmer C; Ritchie K; Tzourio C; Amouyel P; Ducimetière P; Empana JP Heart; 2012 Apr; 98(8):650-5. PubMed ID: 22505463 [TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes. Gurka MJ; Guo Y; Filipp SL; DeBoer MD Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794 [TBL] [Abstract][Full Text] [Related]
13. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study. Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788 [TBL] [Abstract][Full Text] [Related]
14. Frequency and Risk Factors Association with Metabolic Syndrome among the Hypertensive Patients in Jashore, Bangladesh. Acherjya GK; Ali M; Tarafder K; Deb SR; Dan KK; Sarker HN; Amin MR Mymensingh Med J; 2024 Jul; 33(3):822-831. PubMed ID: 38944728 [TBL] [Abstract][Full Text] [Related]
15. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Lim HS; Lip GY; Beevers DG; Blann AD Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044 [TBL] [Abstract][Full Text] [Related]
16. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390 [TBL] [Abstract][Full Text] [Related]
18. The most appropriate cut-off point of anthropometric indices in predicting the incidence of metabolic syndrome and its components. Farhangiyan Z; Latifi SM; Rashidi H; Shahbazian H Diabetes Metab Syndr; 2019; 13(4):2739-2745. PubMed ID: 31405702 [TBL] [Abstract][Full Text] [Related]
19. Using Cluster Analysis to Identify Metabolic Syndrome Components and Physical Fitness in Patients with Metabolic Syndrome. Yiğit Ş; Akıncı B; Ekşi BÜ; Dayıcan DK; Çalıkoğlu F; Çelik Y; Yeldan İ; Satman İ Metab Syndr Relat Disord; 2024 Sep; 22(7):558-565. PubMed ID: 38721973 [No Abstract] [Full Text] [Related]
20. Metabolic syndrome in patients with first-ever ischemic stroke: prevalence and association with coronary heart disease. Liang Y; Yan Z; Hao Y; Wang Q; Zhang Z; She R; Wang P; Du Y; Lau JT; Dekker J; Bai B; Qiu C Sci Rep; 2022 Jul; 12(1):13042. PubMed ID: 35906390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]